Proteomic Studies of Cholangiocarcinoma and Hepatocellular Carcinoma Cell Secretomes

Cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC) occur with relatively high incidence in Thailand. The secretome, proteins secreted from cancer cells, are potentially useful as biomarkers of the diseases. Proteomic analysis was performed on the secreted proteins of cholangiocarcinoma (HuCCA-1) and hepatocellular carcinoma (HCC-S102, HepG2, SK-Hep-1, and Alexander) cell lines. The secretomes of the five cancer cell lines were analyzed by SDS-PAGE combined with LC/MS/MS. Sixty-eight proteins were found to be expressed only in HuCCA-1. Examples include neutrophil gelatinase-associated lipocalin (lipocalin 2), laminin 5 beta 3, cathepsin D precursor, desmoplakin, annexin IV variant, and annexin A5. Immunoblotting was used to confirm the presence of lipocalin 2 in conditioned media and cell lysate of 5 cell lines. The results showed that lipocalin 2 was a secreted protein which is expressed only in the conditioned media of the cholangiocarcinoma cell line. Study of lipocalin 2 expression in different types of cancer and normal tissues from cholangiocarcinoma patients showed that lipocalin 2 was expressed only in the cancer tissues. We suggest that lipocalin 2 may be a potential biomarker for cholangiocarcinoma.

[1]  E. Diamandis,et al.  Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines , 2007, Molecular & Cellular Proteomics.

[2]  I. Ladunga,et al.  Large-scale predictions of secretory proteins from mammalian genomic and EST sequences. , 2000, Current opinion in biotechnology.

[3]  B. V. Van Beers.  Diagnosis of cholangiocarcinoma. , 2008, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[4]  N. Bhamarapravati,et al.  Culturing of human hepatocellular carcinoma. A simple and reproducible method. , 1985, The American journal of pathology.

[5]  Jie Su,et al.  A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma. , 2007, Archives of otolaryngology--head & neck surgery.

[6]  Stitaya Sirisinha,et al.  Proteomic analysis of cholangiocarcinoma cell line , 2004, Proteomics.

[7]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[8]  M. Beaujouin,et al.  Cathepsin D overexpressed by cancer cells can enhance apoptosis-dependent chemo-sensitivity independently of its catalytic activity. , 2008, Advances in experimental medicine and biology.

[9]  J. Casal,et al.  Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling. , 2008, Journal of proteome research.

[10]  H. Tschesche,et al.  A 25 kDa α2‐microglobulin‐related protein is a component of the 125 kDa form of human gelatinase , 1992, FEBS letters.

[11]  Santosh B Reddy,et al.  Current approaches to the diagnosis and treatment of cholangiocarcinoma , 2006, Current gastroenterology reports.

[12]  S. Moss,et al.  Annexins: from structure to function. , 2002, Physiological reviews.

[13]  L. Pannell,et al.  Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. , 2006, Journal of proteome research.

[14]  S. Sirisinha,et al.  Identification and potential use of a soluble tumor antigen for the detection of liver‐fluke‐associated cholangiocarcinoma induced in a hamster model , 1994, International journal of cancer.

[15]  S. Sirisinha,et al.  Establishment and characterization of a cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer. , 1991, Asian Pacific journal of allergy and immunology.

[16]  B. Aggarwal,et al.  Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. , 2008, Cancer research.

[17]  Hsin‐Yi Wu,et al.  Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry. , 2009, Journal of proteome research.

[18]  A. Loukas,et al.  Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificity. , 2009, The international journal of biochemistry & cell biology.

[19]  Candida N. Perera,et al.  Identification of Proteins Secreted from Leptin Stimulated MCF-7 Breast Cancer Cells: A Dual Proteomic Approach , 2008, Experimental biology and medicine.

[20]  S. Moss,et al.  Annexins: linking Ca2+ signalling to membrane dynamics , 2005, Nature Reviews Molecular Cell Biology.

[21]  D. Sonakul,et al.  Hepatic carcinoma with opisthorchiasis. , 1978, The Southeast Asian journal of tropical medicine and public health.

[22]  G. Berchem,et al.  Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis , 2002, Oncogene.

[23]  Khajeelak Chiablaem,et al.  Comparison of membrane‐associated proteins in human cholangiocarcinoma and hepatocellular carcinoma cell lines , 2007, Proteomics. Clinical applications.

[24]  Kai-Ping Chang,et al.  Cancer cell‐secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model , 2005, Proteomics.

[25]  J. McGrath,et al.  Molecular abnormalities of the desmosomal protein desmoplakin in human disease , 2005, Clinical and experimental dermatology.

[26]  D. M. Lloyd,et al.  Elevation of Carbohydrate Antigen 19.9 in Benign Hepatobiliary Conditions and Its Correlation with Serum Bilirubin Concentration , 2008, Digestive Diseases and Sciences.

[27]  D. Lin,et al.  Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer. , 2007, Journal of proteome research.

[28]  A. Carbone,et al.  CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma. , 2008, Cancer research.

[29]  Troels Z. Kristiansen,et al.  A Proteomic Analysis of Human Bile* , 2004, Molecular & Cellular Proteomics.

[30]  Y. Maehara,et al.  Aberrant expression of laminin gamma 2 chain and its prognostic significance in intrahepatic cholangiocarcinoma according to growth morphology , 2004, Modern Pathology.

[31]  R. Schulte‐Hermann,et al.  A novel technique to specifically analyze the secretome of cells and tissues , 2005, Electrophoresis.

[32]  S. Sell,et al.  Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. , 1989, The American journal of pathology.

[33]  G. Giannelli,et al.  Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  S. Hirohashi,et al.  Laminin 5 β3 and γ 2 chains are frequently coexpressed in cancer cells , 2004 .